Ivermectin-luminol en es it fr

Ivermectin-luminol Brand names, Ivermectin-luminol Analogs

Ivermectin-luminol Brand Names Mixture

  • No information avaliable

Ivermectin-luminol Chemical_Formula


Ivermectin-luminol RX_link


Ivermectin-luminol fda sheet

Ivermectin-luminol msds (material safety sheet)

Ivermectin-luminol MSDS

Ivermectin-luminol Synthesis Reference

No information avaliable

Ivermectin-luminol Molecular Weight

342.296 g/mol

Ivermectin-luminol Melting Point

173 - 178 oC

Ivermectin-luminol H2O Solubility

764 mg/mL

Ivermectin-luminol State


Ivermectin-luminol LogP


Ivermectin-luminol Dosage Forms

Liquid; Powder; Solution; Syrup

Ivermectin-luminol Indication

For the treatment of constipation and hepatic encephalopathy.

Ivermectin-luminol Pharmacology

Therapeutically, lactulose has laxative and ammonia-detoxifying actions. In treating constipation lactulose metabolites draw water into the bowel, causing a cathartic effect through osmotic action.

Ivermectin-luminol Absorption

Poorly absorbed from the gastrointestinal tract as no human enzyme that is capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue.

Ivermectin-luminol side effects and Toxicity

LD50=18.2 g/kg (oral, rat). Side effects include diarrhea and resultant dehydration.

Ivermectin-luminol Patient Information


Ivermectin-luminol Organisms Affected

Humans and other mammals